StreetAlpha.app
Home › Stocks › BIO

Bio-rad Laboratories, Inc. (BIO)

Healthcare
$358.25
▼ −0.65%
LAST CLOSE · NOV 17

Bio-Rad makes life science research tools and clinical diagnostic test systems for labs, hospitals and research institutions. It last closed at $358.25 on Nov 17, down 0.65% on the day. BIO reports earnings on Thu, Feb 11, 2027. In the past 30 days there were 2 dark pool prints totaling $4.5M, the largest $2.5M.

AI Auto Pilots
Is BIO in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$2.6B
+1.4% vs a year ago
Net income
$1.0B
39.5% margin
EPS (diluted)
$37.64
Free cash flow
$329.1M
12.7% margin
Balance sheet
Cash & equivalents
$465.3M
At Sep 30
Debt
$1.2B
At Sep 30
Shareholder equity
$7.6B
Buybacks
$79.3M
Last 12 months
Employees8,300 (Mar 16, 2023)
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $2.9B$2.9BFY2021FY2022: $2.8B$2.8BFY2022FY2023: $2.7B$2.7BFY2023FY2024: $2.6B$2.6BFY2024FY2025: $2.6B$2.6BFY2025

From BIO's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 4). Last 12 months adds up the four latest quarters.

Next report
Feb 11
2027 · Time not announced
Consensus EPS forecast
$2.83
$688.7M revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated BIO in the past 90 days, not enough for a consensus
Average 12-month target
$440.00
▲ 22.8% upside

Based on 1 analyst who set a price target on BIO in the past 90 days. The average target is $440.00, with a high of $440.00 and a low of $440.00, compared with the last close of $358.25.

Low $440.00Avg $440.00High $440.00
Blue marker: last close $358.25
Highest target$440.00
Average target$440.00
Lowest target$440.00
Latest rating changes
RBC CapitalTarget raised
Nov 5Buy$390 → $440
RBC CapitalTarget raised
Aug 7Buy$370 → $390
CitigroupMaintained
Aug 5Hold$330
RBC CapitalTarget raised
Aug 5Buy$320 → $370
Wells FargoMaintained
Aug 5Hold$330
DateFirmActionRatingPrice target
Nov 5RBC CapitalTarget raisedBuy$390 → $440
Aug 7RBC CapitalTarget raisedBuy$370 → $390
Aug 5CitigroupMaintainedHold$330
Aug 5RBC CapitalTarget raisedBuy$320 → $370
Aug 5Wells FargoMaintainedHold$330
Loading…

Technical Analysis

BIO · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend

The stock is 4% below its 20 day and 4% below its 50 day average. It is 11% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the Pivot S1 at $355.83, and the nearest resistance the Pivot at $358.76.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 3.3%/day
Key levels
$396.2352 week high+10.6%
$373.8420 day average+4.4%
$372.0050 day average+3.8%
$365.00Swing high (Aug 13)+1.9%
$361.18Pivot R1+0.8%
$358.76Pivot+0.1%
$358.25Last close
$355.83Pivot S1−0.7%
$354.89100 day average−0.9%
$353.97Swing low (Oct 8)−1.2%
$317.63200 day average−11.3%
$236.7352 week low−33.9%
Indicators
RSI (14)41.21Middle of its rangeNeutral
MACD-0.57Below its signal lineBearish
Stochastic22.4Middle of its rangeNeutral
ADX (14)15.5No clear trend
Williams %R-85.5Oversold below −80, overbought above −20Oversold
CCI (20)-120.9Oversold below −100, overbought above 100Oversold
Rate of change−4.4%Change over 10 sessionsBearish
ATR (14)$11.94Typical daily range, 3.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for BIO

What happened before

See how BIO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow BIO usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How BIO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in BIO in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
2
Notional
$4.5M
Largest print
$2.5M
Loading…

BIO Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●194 buying vs 171 selling
  • ▼Shares held by funds -14.8%
  • ▲Funds holding +16
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding417401+4.0%
In funds' top 1054+25.0%
Held by funds–––
New / increased63 / 13156 / 114+14.1%
Reduced / sold out132 / 39155 / 53−17.8%
Put/call ratio0.62––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BIO institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BIO is in one of them and how their past BIO trades turned out.

BIO in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BIO in an article yet. Here's the latest on the wider market.

BIO Congress Trades

All congress trades →
Trades, 12 months
1
Buys
0
0%
Sells
1
100%
People
1
Last filed Apr 10
Who traded BIO · since 2015
Latest 5 filings of 28
$1K – $15KTraded Jan 30, 2026Filed Apr 10, 2026
$1K – $15KTraded Apr 28, 2025Filed Sep 9, 2025
$1K – $15KTraded Nov 3, 2023Filed Dec 6, 2023
$15K – $50KTraded Oct 26, 2023Filed Nov 8, 2023
$1K – $15KTraded Oct 2, 2023Filed Nov 8, 2023
PersonTypeAmountTradedFiledDelay
Arjun ModyExecutive branchSell$1K – $15KJan 30, 2026Apr 10, 202670 d
Lori Chavez-DeRemerExecutive branchSell$1K – $15KApr 28, 2025Sep 9, 2025134 d
Ro KhannaD · CASell$1K – $15KNov 3, 2023Dec 6, 202333 d
Ro KhannaD · CASell$15K – $50KOct 26, 2023Nov 8, 202313 d
Ro KhannaD · CABuy$1K – $15KOct 2, 2023Nov 8, 202337 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Bio-rad Laboratories

Bio-Rad is a life science and clinical diagnostics company based in Hercules, California. Its life science unit makes instruments, systems, reagents, and consumables used to separate, purify, and measure cells, proteins, and nucleic acids. Its diagnostics unit supplies test systems, software, test kits, and quality controls for the in vitro diagnostics market. Customers include universities, research institutions, pharmaceutical and biotechnology companies, hospital and reference laboratories, and food testing labs.

Headquarters
Hercules, CA
Founded
1952